SCHEMBL8109328

SCHEMBL8109328

CSCc1cccc(C(C)C)c1N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
GABRB2 P47870 3/20 0.38
FAAH O00519 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
GABRB1 P18505 1/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR2C P28335 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
HTR2B P41595 1/20 0.38
GABRA2 P47869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5575889 0.80 GABRA1 (0.43) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL18946087 0.80 GABRA1 (0.41) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL770339 0.79 GABRA1 (0.42) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL29631719 0.79 GABRA1 (0.42) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL22415013 0.77 GABRA1 (0.50) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL3962423 0.76 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRB2FAAH
Hydrochloric Acid SCHEMBL8107458 0.76 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL104314 0.75 GABRA1 (0.55) GABRA1GABRG2GABRB3GABRB2FAAH
SCHEMBL9090960 0.75 GABRA1 (0.41) GABRA1GABRB2ALOX5APFEN1NOS3
SCHEMBL10904462 0.75 CD44 (0.46) CA1CA2CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0632036-B1 Amide derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses SANKYO CO (JP) 2000-03-01 EP disclosed
US-5614550-A ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS SANKYO COMPANY, LIMITED (JP) 1997-03-25 US disclosed
US-5534529-A Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses SANKYO COMPANY, LIMITED (JP) 1996-07-09 US disclosed
EP-0632036-A2 Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses SANKYO COMPANY LIMITED (JP) 1995-01-04 EP disclosed